.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Teva
Farmers Insurance
Mallinckrodt
Cipla
Express Scripts
Dow
Johnson and Johnson
Baxter
McKinsey

Generated: November 24, 2017

DrugPatentWatch Database Preview

Merz Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for MERZ PHARMS, and what generic alternatives to MERZ PHARMS drugs are available?

MERZ PHARMS has two approved drugs.

There are two US patents protecting MERZ PHARMS drugs.

Summary for Merz Pharms

US Patents:2
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merz Pharms
CUVPOSA
glycopyrrolate
SOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► Subscribe ► Subscribe
Merz Pharms
CUVPOSA
glycopyrrolate
SOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► Subscribe ► Subscribe
Merz Pharms
CUVPOSA
glycopyrrolate
SOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► Subscribe► Subscribe
Merz Pharms
ERYMAX
erythromycin
SOLUTION;TOPICAL062508-002Jul 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MERZ PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
glycopyrrolate
Oral Solution1 mg/5 mL
CUVPOSA
6/20/2012

Non-Orange Book Patents for Merz Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,091,236Method for increasing the bioavailability of glycopyrrolate► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Army
Daiichi Sankyo
UBS
Cantor Fitzgerald
Healthtrust
Julphar
Covington
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot